Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line

Abstract

Loss of heterozygosity of the distal region of chromosome 1p where tumor suppressor gene(s) might harbor is frequently observed in many human cancers including neuroblastoma (NBL) with MYCN amplification and poor prognosis. We have identified for the first time a homozygously deleted region at the marker D1S244 within the smallest region of overlap at 1p36.2-p36.3 in two NBL cell lines, NB-1 and NB-C201 (MASS-NB-SCH1), although our genotyping has suggested the possibility that both lines are derived from the same origin. The 800-kb PAC contig covering the entire region of homozygous deletion was made and partially sequenced (about 60%). The estimated length of the deleted region was 500 kb. We have, thus far, identified six genes within the region which include three known genes (DFF45, PGD, and CORT) as well as three other genes which have been reported during processing our present project for the last 3½ years (HDNB1/UFD2, KIAA0591F/KIF1B-β, and PEX14). They include the genes related to apoptosis, glucose metabolism, ubiquitin-proteasome pathway, a neuronal microtubule-associated motor molecule and biogenesis of peroxisome. At least three genes (HDNB1/UFD2, KIAA0591F/KIF1B-β, and PEX14) were differentially expressed at high levels in favorable and at low levels in unfavorable subsets of primary neuroblastoma. Since the 1p distal region is reported to be imprinted, those differentially expressed genes could be the new members of the candidate NBL suppressor, although RT-PCR-SSCP analysis has demonstrated infrequent mutation of the genes so far identified. Full-sequencing and gene prediction for the region of homozygous deletion would elucidate more detailed structure of this region and might lead to discovery of additional candidate genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Amler LC, Corvi R, Praml C, Savelyeva L, Le Paslier D and Schwab M. . 1995 Oncogene 10: 1095–1101.

  • Bolande RP. . 1974 Hum. Pathol. 5: 409–429.

  • Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM. . 1984 Science 224: 1121–1124.

  • Carling T, Imanishi Y, Gaz RD and Arnold A. . 1999 Int. J. Cancer 83: 80–82.

  • Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voute PA, Westerveld A and Versteeg R. . 1993 Nat. Genet. 4: 187–190.

  • Caron H. . 1995 Med. Pediatr. Oncol. 24: 215–221.

  • Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F and Versteeg R. . 1995 Oncogene 10: 291–297.

  • de Lecea L, Ruiz-Lozano P, Danielson PE, Peelle-Kirley J, Foye PE, Frankel WN and Sutcliffe JG. . 1997 Genomics 42: 499–506.

  • Diccianni MB, Chau LS, Batova A, Vu TQ and Yu AL. . 1996 Cancer Lett. 104: 183–192.

  • Dracopoli NC, Stanger BZ, Lager M and Housman DE. . 1988 Genomics 3: 124–128.

  • Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S. . 1998 Nature 391: 43–50.

  • Enomoto H, Ozaki T, Takahashi E, Nomura N, Tabata S, Takahashi H, Ohnuma N, Tanabe M, Iwai J, Yoshida H, Matsunaga T and Sakiyama S. . 1994 Oncogene 9: 2785–2791.

  • Fukusumi S, Kitada C, Takekawa S, Kizawa H, Sakamoto J, Miyamoto M, Hinuma S, Kitano K and Fujino M. . 1997 Biochem. Biophys. Res. Commun. 232: 157–163.

  • Hattori M, Tsukahara F, Furuhata Y, Tanahashi H, Hirose M, Saito M, Tsukuni S and Sakaki Y. . 1997 Nucleic Acids Res. 25: 1802–1808.

  • He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, Nakagawara A, Brodeur GM, Shi YE and Huang S. . 1998 Cancer Res. 58: 4238–4244.

  • Hiraiwa H, Hamazaki M, Takata A, Kikuchi H and Hata J. . 1997 Cancer 79: 2036–2044.

  • Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D and Nakagawara A. . 1999 Oncogene 18: 1061–1066.

  • Imashuku S, Inui A, Nakamura T, Tanaka J and Miyake S. . 1973 J. Clin. Endocrinol. Metab. 36: 931–936.

  • Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA and de Jong PJ. . 1994 Nat. Genet. 6: 84–89.

  • Johnson ES, Ma PC, Ota IM and Varshavsky A. . 1995 J. Biol. Chem. 270: 17442–17456.

  • Jones PA and Laird PW. . 1999 Nature Genet. 21: 163–167.

  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. . 1997 Cell 90: 809–819.

  • Knudson AG. . 1971 Proc. Natl. Acad. Sci. USA 68: 820–823.

  • Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU and Jentsch S. . 1999 Cell 96: 635–644.

  • Lahti JM, Valentine M, Xiang J, Jones B, Amann J, Grenet J, Richmond G, Look AT and Kidd VJ. . 1994 Nat. Genet. 7: 370–375.

  • Liu X, Zou H, Slaughter C and Wang X. . 1997 Cell 89: 175–184.

  • Martinsson T, Sjoberg RM, Hedborg F and Kogner P. . 1995 Cancer Res. 55: 5681–5686.

  • Martinsson T, Sjoberg RM, Hedborg F and Kogner P. . 1997 Cancer Genet. Cytogenet. 95: 183–189.

  • Nagai M, Ichimiya S, Ozaki T, Seki N, Mihara M, Furuta S, Ohira M, Tomioka N, Nomura N, Sakiyama S, Kubo O, Takakura K, Hori T and Nakagawara A. . 2000 Int. J. Oncol. 16: 907–916.

  • Nagase T, Ishikawa K, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O. . 1998 DNA Res. 5: 31–39.

  • Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H and Hirokawa N. . 1994 Cell 79: 1209–1220.

  • Pukatzki S, Tordilla N, Franke J and Kessin RH. . 1998 J. Biol. Chem. 273: 24131–24138.

  • Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelenat H, Thomas G and Delattre O. . 1994 Genes Chromosomes Cancer 10: 275–281.

  • Schwab M, Praml C and Amler LC. . 1996 Genes Chromosomes Cancer 16: 211–229.

  • Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, Todo S, Adachi W, Amano J and Nakagawara A. . 1998 Int. J. Oncol. 13: 319–323.

  • Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y and Kaneko Y. . 1994 Genes Chromosomes Cancer 10: 30–39.

  • Takemura R, Nakata T, Okada Y, Yamazaki H, Zhang Z and Hirokawa N. . 1996 J. Neurosci. 16: 31–35.

  • The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF and Bernards A. . 1993 Nat. Genet. 3: 62–66.

  • Tsui SK, Chan JY, Waye MM, Fung KP and Lee CY. . 1996 Biochem. Genet. 34: 367–373.

  • White PS, Kaufman BA, Marshall HN and Brodeur GM. . 1993 Genes Chromosomes Cancer 7: 102–108.

  • White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S and Brodeur GM. . 1995 Proc. Natl. Acad. Sci. USA 92: 5520–5524.

  • Will GK, Soukupova M, Hong X, Erdmann KS, Kiel JA, Dodt G, Kunau WH and Erdmann R. . 1999 Mol. Cell Biol. 19: 2265–2277.

  • Wise CA, Clines GA, Massa H, Trask BJ and Lovett M. . 1997 Genome Res. 7: 10–16.

Download references

Acknowledgements

The authors thank Drs S Ichimiya, Y Nimura, and N Takada for helpful discussions, to Drs M Nagai, M Naka, T Iijima and S Saitoh for experimental support, to Ms A Morohashi, N Sugimitsu, E Kojima for technical assistance. We are grateful to Drs M Hamazaki and H Hiraiwa for providing the cell line and useful discussion and Dr M Oshimura for giving the hybrid cells. The authors also thank the hospitals and institutes collaborating with the Japanese Neuroblastoma Study Group for providing surgical specimens.

This work was supported in part by a grant-in-aid from the Ministry of Health and Welfare for a New Comprehensive 10-year Strategy for Cancer Control, Japan, by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan, and by a grant from Uehara Memorial Foundation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohira, M., Kageyama, H., Mihara, M. et al. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19, 4302–4307 (2000). https://doi.org/10.1038/sj.onc.1203786

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203786

Keywords

This article is cited by

Search

Quick links